Yuhong Jiang
Chengdu, 610031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Deciphering the immunomodulatory code: how metal nanoadjuvants orchestrate intracellular immune signaling cascades.
Journal: Biochemical pharmacology
Published: January 20, 2026
GPCR signaling from endosome: mechanistic insights and therapeutic potentials.
Journal: European journal of pharmacology
Published: August 12, 2025
Manganese oxide nanoparticle acts as a promising immune adjuvant via tuning ferroptosis signaling.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 08, 2025
A novel designed fully peptide-based PROTAC, FPP29, demonstrates its potent cytotoxic effects to liver cancer HCCLM3 cells by targeting FOXM1.
Journal: Bioorganic chemistry
Published: March 25, 2025
PFOA exposure causes kidney injury via disruption of lipid metabolism mediated by PPARα signaling pathway: An integrated analysis.
Journal: Toxicology letters
Published: March 17, 2025
Navigating a challenging path: precision disease treatment with tailored oral nano-armor-probiotics.
Navigating a challenging path: precision disease treatment with tailored oral nano-armor-probiotics.
Journal: Journal of nanobiotechnology
Published: October 23, 2024
A novel peptide CP29L, selected from the phage displayed cyclic random heptapeptide library, demonstrates its potent inhibitory effects to liver cancer HCCLM3 cells by targeting FOXM1.
Journal: European journal of pharmacology
Published: August 09, 2024
PAR2 deficiency tunes inflammatory microenvironment to magnify STING signalling for mitigating cancer metastasis via anionic CRISPR/Cas9 nanoparticles.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 07, 2023
Interplay between G protein-coupled receptors and nanotechnology.
Journal: Acta biomaterialia
Published: March 14, 2023
Multifunctional magnetic Fe3O4/Cu2O-Ag nanocomposites with high sensitivity for SERS detection and efficient visible light-driven photocatalytic degradation of polycyclic aromatic hydrocarbons (PAHs).
Journal: Journal of colloid and interface science
Published: June 19, 2022
PAR2 blockade reverses osimertinib resistance in non-small-cell lung cancer cells via attenuating ERK-mediated EMT and PD-L1 expression.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: April 11, 2021
Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR Transactivation.
Journal: Frontiers in pharmacology
Published: November 02, 2020
Last Updated: 09/26/2026